Coca-Cola Consolidated, Inc.
COKE
$192.39
-1.34%
Coca-Cola Consolidated, Inc. is the largest Coca-Cola bottler in the United States, responsible for distributing, marketing, and manufacturing a wide range of nonalcoholic beverages, including sparkling drinks like Coca-Cola and still beverages such as bottled water, teas, coffees, and sports drinks. As a key player in the non-alcoholic beverage industry, the company operates as a regional bottler with a dominant market position in its territories. The current investor narrative centers on the company's strong revenue growth driven by price increases and volume recovery, coupled with margin expansion and robust free cash flow generation, which have fueled a significant stock price rally over the past year.…
COKE
Coca-Cola Consolidated, Inc.
$192.39
Investment Opinion: Should I buy COKE Today?
Rating: Hold. Thesis: COKE offers strong revenue growth and cash flow but is burdened by negative equity and earnings uncertainty, making it a hold for now. The lack of analyst consensus and wide gap between trailing and forward P/E warrant caution.
Supporting Evidence: Revenue grew 16.88% YoY in Q1 2026, accelerating from prior quarters. Operating margin expanded to 12.86% from 12.01% a year ago. Free cash flow TTM is $662.1M, providing financial flexibility. Trailing P/E of 19.78x is below the industry average of 25x, suggesting value. However, the forward P/E of 4.74x implies a dramatic earnings decline, which is a major concern. The PEG ratio of 1.87x indicates the stock is not cheap on a growth-adjusted basis.
Risks & Conditions: The Hold rating would upgrade to Buy if the company demonstrates sustained revenue growth above 10% and provides guidance that alleviates forward P/E concerns, or if the stock pulls back to the $150 level (near the 52-week low). It would downgrade to Sell if revenue growth decelerates below 5% or if the company reports a net loss. The stock appears fairly valued relative to its history (trailing P/E near the middle of its 5-year range of 8x-28x) but overvalued on a PEG basis. Given the risks, a Hold is appropriate until earnings visibility improves.
Sign up to view all
COKE 12-Month Price Forecast
COKE's strong revenue growth and cash flow are offset by negative equity and a puzzling forward P/E. The base case of moderate growth and stable margins is most likely, with a 50% probability. The bull case requires sustained high growth and margin expansion, while the bear case hinges on a growth slowdown. The neutral stance reflects the balanced risk/reward. An upgrade to bullish would require clarity on earnings sustainability, while a downgrade to bearish would follow a significant growth deceleration.
Wall Street consensus
Insufficient analyst coverage available. Only 1 analyst covers the stock, with no consensus recommendation or target price provided. This limited coverage implies COKE is a small-cap or mid-cap stock with lower institutional interest, which can lead to higher volatility and less efficient price discovery. Investors should conduct their own due diligence and consider the lack of analyst guidance as a risk factor.
Given the sparse analyst data, no target range or sentiment analysis is possible. The absence of recent upgrades or downgrades (the last rating was a Neutral from Citigroup in 2016) further underscores the lack of active coverage. This means the stock may be overlooked by the broader market, potentially creating opportunities for informed investors but also increasing the risk of mispricing.
Drowning in data?
Find the real signal!
Bulls vs Bears: COKE Investment Factors
COKE presents a mixed picture: strong revenue growth, expanding margins, and robust cash flow generation are bullish, while negative equity, a low forward P/E, and limited analyst coverage are bearish. The bull case currently has stronger evidence given the accelerating revenue and margin expansion, but the negative equity and earnings uncertainty are significant risks. The single most important tension is whether the company can sustain its earnings growth trajectory; if it does, the stock is undervalued, but if earnings normalize, the forward P/E suggests a sharp decline. The outcome of this tension will determine the investment thesis.
Bullish
- Strong Revenue Growth Accelerating: Q1 2026 revenue grew 16.88% YoY to $1.847B, accelerating from 9.1% in Q4 2025. This robust top-line expansion demonstrates pricing power and volume recovery, outpacing the beverage industry average growth of ~5%.
- Expanding Operating Margins: Operating margin improved to 12.86% in Q1 2026 from 12.01% a year ago, reflecting effective cost control. Gross margin remained stable at 39.37%, indicating the company can maintain profitability despite input cost pressures.
- Robust Free Cash Flow Generation: Free cash flow TTM is $662.1M, providing ample liquidity for debt reduction, share buybacks, or dividends. Operating cash flow of $205.3M in Q1 2026 covers capital expenditures and interest expenses comfortably.
- Attractive Valuation vs. Industry: Trailing P/E of 19.78x is below the beverage industry average of ~25x, and PS ratio of 1.56x is below the industry average of 2.5x. This suggests the stock is undervalued relative to peers on these metrics.
Bearish
- Negative Equity from Aggressive Buybacks: Debt-to-equity ratio is -4.06 due to negative shareholders' equity, a result of extensive share repurchases and debt. This financial structure increases risk, as the company has no equity cushion to absorb losses.
- Forward P/E Implies Earnings Decline: Forward P/E of 4.74x is extremely low, suggesting the market expects a dramatic earnings drop. This disconnect from the trailing P/E of 19.78x is a red flag, potentially indicating one-time gains or unsustainable profitability.
- Limited Analyst Coverage and Guidance: Only 1 analyst covers the stock with no consensus recommendation or target price. This lack of institutional attention can lead to inefficient pricing and higher volatility, making due diligence more challenging.
- High PEG Ratio Suggests Overvaluation: PEG ratio of 1.87x indicates the stock is trading at a premium to its expected growth rate. This implies that growth expectations may already be priced in, limiting upside potential.
COKE Technical Analysis
COKE is in a sustained uptrend, with a 1-year price change of +65.19%, significantly outperforming the S&P 500's +16.47%. The current price of $184.70 sits at 64.5% of its 52-week range ($110.40 to $219.65), indicating the stock is in the upper half of its range but not overextended, suggesting room for further upside if momentum continues. The stock's beta of 0.534 implies it is less volatile than the market, making it a relatively defensive holding within the consumer defensive sector.
Short-term momentum shows mixed signals: the 1-month change is +4.03%, while the 3-month change is -5.57%, indicating a recent pullback from the highs. This divergence from the strong 1-year uptrend could signal a temporary consolidation or mean reversion, rather than a trend reversal, given the stock's relative strength versus the S&P 500 (1-month relative strength +3.25%, 3-month relative strength -9.07%). The recent price action from the May 2026 low of $163.43 to the current level suggests a recovery attempt, but volume data is not available to confirm.
Key support is at the 52-week low of $110.40, while resistance is at the 52-week high of $219.65. A breakout above $219.65 would signal a continuation of the uptrend, potentially targeting new highs, while a breakdown below $110.40 would be a bearish signal. With a beta of 0.534, COKE is significantly less volatile than the market, meaning it may offer downside protection during market selloffs but could lag during strong rallies.
Beta
0.53
0.53x market volatility
Max Drawdown
-24.7%
Largest decline past year
52-Week Range
$110-$220
Price range past year
Annual Return
+67.6%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | +0.1% | -1.6% |
| 3m | -6.2% | +1.5% |
| 6m | +26.5% | +5.4% |
| 1y | +67.6% | +14.8% |
| ytd | +28.4% | +7.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
Revenue is growing strongly, with the most recent quarterly revenue of $1.847 billion (Q1 2026) representing a 16.88% YoY increase from $1.580 billion in Q1 2025. This growth is accelerating from the prior quarter's 9.1% YoY growth (Q4 2025 revenue of $1.904 billion vs. $1.746 billion in Q4 2024). The Nonalcoholic Beverage segment, which generated $1.834 billion in Q1 2026, is the primary growth driver, while the All Other segment contributed $89.5 million. The revenue trajectory is robust, supporting the investment case for continued market share gains and pricing power.
The company is highly profitable, with net income of $111.6 million in Q1 2026 and a net margin of 6.04%. Gross margin is stable at 39.37% in Q1 2026, slightly down from 39.69% in Q1 2025 but up from 38.21% in Q4 2025. Operating margin improved to 12.86% from 12.01% a year ago, indicating effective cost control. The company's profitability is solid and margins are expanding, which is positive for the investment thesis.
Balance sheet and cash flow are strong. The company generated $205.3 million in operating cash flow and $142.2 million in free cash flow in Q1 2026. Free cash flow TTM is $662.1 million, providing ample liquidity. The current ratio is 1.26, indicating adequate short-term liquidity. However, the debt-to-equity ratio is -4.06, reflecting negative shareholders' equity due to share buybacks and debt, which is a risk. ROE is negative (-77.1%) due to negative equity, but ROA is a healthy 12.7%. The company's cash flow generation is robust, reducing reliance on external financing.
Quarterly Revenue
$1.8B
2026-04
Revenue YoY Growth
+16.9%
YoY Comparison
Gross Margin
39.4%
Latest Quarter
Free Cash Flow
$662108000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Since net income is positive ($111.6 million), we lead with the P/E ratio. The trailing P/E is 19.78x, while the forward P/E is 4.74x, implying a dramatic earnings growth expectation. The large gap between trailing and forward P/E suggests the market expects a significant earnings decline in the coming year, which is a red flag. The PEG ratio of 1.87 indicates that the stock is trading at a premium to its expected growth rate, suggesting it may be overvalued relative to growth.
Compared to the industry, COKE's trailing P/E of 19.78x is below the beverage industry average of around 25x, suggesting a discount. However, the forward P/E of 4.74x is extremely low, likely due to expected earnings normalization. The PS ratio of 1.56x is below the industry average of 2.5x, indicating a potential value opportunity. The EV/EBITDA of 13.55x is in line with industry peers. The discount may be justified by the company's negative equity and high debt levels.
Historically, COKE's trailing P/E has ranged from 8x to 28x over the past five years. The current 19.78x is near the middle of this range, suggesting fair valuation relative to its own history. The P/E was as low as 8.1x in Q3 2022 and as high as 27.9x in Q1 2025. The current level indicates the market is pricing in moderate expectations, not overly optimistic or pessimistic.
PE
19.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The most critical financial risk is the negative shareholders' equity (-4.06 debt-to-equity), resulting from aggressive share buybacks and debt accumulation. This leaves the company with no equity buffer, increasing financial fragility. Additionally, the forward P/E of 4.74x implies the market expects a significant earnings decline, which could materialize if revenue growth slows or margins contract. The company's net margin of 6.04% in Q1 2026, while healthy, is sensitive to input cost inflation and pricing power. If the company cannot pass on cost increases, margins could compress, impacting cash flow generation.
Market & Competitive Risks: COKE operates in the competitive non-alcoholic beverage industry, facing pressure from private labels and new entrants. The stock's beta of 0.534 indicates low market correlation, but its recent pullback of 5.57% over 3 months suggests vulnerability to sector rotation. The lack of analyst coverage (only 1 analyst) means the stock may be mispriced or overlooked, leading to potential volatility. Regulatory risks include potential sugar taxes or environmental regulations that could increase costs. The company's reliance on the Coca-Cola brand also poses a risk if consumer preferences shift away from carbonated soft drinks.
Worst-Case Scenario: In a severe downturn, if revenue growth decelerates below 5% and margins contract due to cost pressures, earnings could fall sharply. The stock could decline to its 52-week low of $110.40, representing a 40.2% drop from the current price of $184.70. This scenario could be triggered by a recession, a major competitor gaining market share, or a significant increase in interest rates that increases debt servicing costs. The historical max drawdown of -24.66% provides a reference, but the worst case could be more severe given the negative equity.
FAQ
The key risks are: 1) Financial risk from negative shareholders' equity (debt-to-equity of -4.06), which leaves no equity cushion. 2) Earnings risk: the forward P/E of 4.74x implies a severe earnings decline, which could materialize if revenue growth slows. 3) Competitive risk: the non-alcoholic beverage industry is highly competitive, with pressure from private labels and changing consumer preferences. 4) Limited analyst coverage (only 1 analyst) means less price discovery and potential for mispricing. The most severe risk is a sharp earnings drop that could send the stock to its 52-week low of $110.40, a 40% decline from current levels.
The 12-month outlook is balanced. The base case (50% probability) sees the stock trading between $175 and $200, with revenue growth moderating to 8-10% and margins stable. The bull case (25% probability) targets $210-$230, driven by sustained high growth and margin expansion. The bear case (25% probability) sees the stock falling to $110-$140 if growth disappoints. The most likely scenario is the base case, assuming the company maintains its growth trajectory but does not accelerate. Key assumptions include stable consumer demand and no major cost shocks.
COKE's valuation is mixed. The trailing P/E of 19.78x is below the beverage industry average of ~25x, suggesting it is undervalued relative to peers. The PS ratio of 1.56x is also below the industry average of 2.5x. However, the forward P/E of 4.74x is extremely low, implying the market expects a dramatic earnings decline. The PEG ratio of 1.87x indicates the stock is overvalued on a growth-adjusted basis. Historically, the trailing P/E is near the middle of its 5-year range (8x-28x), suggesting fair valuation. Overall, the stock appears fairly valued based on trailing earnings but overvalued based on growth expectations.
COKE is a mixed proposition. On the positive side, it has strong revenue growth (16.88% YoY), expanding margins, and robust free cash flow of $662.1M TTM. Its trailing P/E of 19.78x is below the industry average, suggesting value. However, the negative equity (-4.06 D/E) and forward P/E of 4.74x (implying a sharp earnings decline) are major concerns. The stock is a good buy for investors who believe the earnings decline is overstated and that growth will continue, but it is risky for conservative investors. A Hold is recommended until earnings visibility improves.
COKE is more suitable for long-term investment given its defensive beta of 0.534 and strong cash flow generation. The company's dominant position in the non-alcoholic beverage industry provides stability, and its revenue growth and margin expansion support a multi-year holding period. However, the negative equity and earnings uncertainty make it less suitable for short-term trading, as the stock can be volatile (recent 3-month decline of 5.57%). A minimum holding period of 3-5 years is recommended to allow the company to address its balance sheet issues and realize the benefits of its growth strategy. Short-term traders should be cautious due to the lack of analyst coverage and potential for sharp moves.
